The Company

CellGenix, which was founded in 1994 as a spin-off of the University Medical Center Freiburg, is an innovative biopharmaceutical company headquartered in Freiburg, Germany. Today it has more than 50 employees.

Based on its extensive experience and one of the most technologically advanced GMP facilities, CellGenix develops, manufactures and markets a variety of products and services for individual cell and protein therapies for cancer and orthopedic patients. Its goal is to achieve a more rapid and efficient transfer of new technologies from medical research to clinical application.

The company owns Metreon Bioproducts GmbH, which was founded in 1996 as Joint venture with Schering AG (Berlin, Germany). Metreon provides GMP clean room facilities class A – D and S2 and L2 laboratories (800 m2 + 600 m2). CellGenix also owns shares in American Fluoroseal Cooperation (Afc) in Gaithersburg, Maryland (USA), and in CellPrep S.A. in Buenos Aires (Argentina).

www.cellgenix.com - Ex vivo Therapeutics, cellular Therapeutics, molecular Therapeutics